LT

Lou Tartaglia

Managing Partner at Cure Ventures

Greater Boston

Overview

Work Experience

Cure Ventures

  • Managing Partner and Co-Founder

    2021 - Current

5AM Ventures

  • Venture Partner

    2018 - 2020

  • Head of 4:59

    2016 - 2018

Solstice Biologics

  • CEO

    2014 - 2015

TR

Third Rock Ventures

  • Partner

    2007 - 2014

GL

Gene Logic

  • General Manager

    2004 - 2007

MP

Millennium Pharmaceuticals

  • VP Metabolic Diseases

    1993 - 2004

G

Genentech

  • Postdoc

    1990 - 1993

Education

Investments

Ablexis

Series A

Total Funding: $12M

Relevant Websites